Search results
Results from the WOW.Com Content Network
It is published by Wiley and was established in 1980. [1] The editor-in-chief is Amanda E. Hargrove (Duke University). [2] The journal publishes critical reviews of topics include pathophysiology, genomics and proteomics, and clinical characteristics of important drugs.
The journal is abstracted and indexed in: EBSCO databases; Biological Abstracts; Chemical Abstracts Service; Current Contents/Life Sciences; Embase; ProQuest databases; Index Medicus, MEDLINE/PubMed; Science Citation Index Expanded; According to the Journal Citation Reports, the journal has a 2023 impact factor of 2.9. [5]
Medical journals are published regularly to communicate new research to clinicians, medical scientists, and other healthcare workers. This article lists academic journals that focus on the practice of medicine or any medical specialty. Journals are listed alphabetically by journal name, and also grouped by the subfield of medicine they focus on.
According to the Journal Citation Reports, the journal has a 2022 impact factor of 3.9. [2] It is thus ranked #11 out of 38 journals within the category of Substance Abuse. However, according to another metric, the TQCC (top quartile citation count), Journal of Substance Use and Addiction Treatment is ranked #1 in that category as of early 2024 ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy is a monthly peer-reviewed medical journal covering human pharmacology and pharmacotherapy, published by Wiley-Blackwell on behalf of the American College of Clinical Pharmacy, of which it is an official journal.
The median annual list price for a new drug was $300,000 in 2023, according to the Reuters analysis of 47 medicines, up from $222,000 a year earlier. ... range in price from $2.2 million for ...
Impact factor. 5.749 (2020) ... that covers drug treatment of psychiatric and neurological disorders. ... the journal has a 2023 impact factor of 7.4. [1] References
Clinical Pharmacology & Therapeutics is a monthly peer-reviewed medical journal which covers research on the nature, action, efficacy, and evaluation of therapeutics. The editor-in-chief is Piet van der Graaf ( Cetara ).